Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 CAD | -1.90% | -4.91% | -53.73% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.73% | 18.49M | |
+60.83% | 62.59B | |
-2.31% | 41.18B | |
+44.42% | 40.29B | |
-8.29% | 27.9B | |
+12.47% | 26.21B | |
-21.82% | 19.09B | |
+5.33% | 13.08B | |
+24.61% | 12.26B | |
+28.02% | 12.05B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Priced US$8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharma